[EN] INHIBITORS OF MUTANT FORMS OF EGFR<br/>[FR] INHIBITEURS DE FORMES MUTANTES DE L'EGFR
申请人:BLUEPRINT MEDICINES CORP
公开号:WO2021133809A1
公开(公告)日:2021-07-01
The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt thereof useful for treating a cancer.
本公开提供了一种由结构公式(I)表示的化合物:或其药用可接受的盐,用于治疗癌症。
Langler, Richard Francis; Steeves, Jennifer Lea, Australian Journal of Chemistry, 1994, vol. 47, # 8, p. 1641 - 1646
作者:Langler, Richard Francis、Steeves, Jennifer Lea
DOI:——
日期:——
Telomerization of butadiene and isoprene with sulfones containing active methine and methylene groups, catalyzed by palladium complexes
作者:G. A. Tolstikov、O. A. Rozentsvet、R. V. Kunakova、N. N. Novitskaya
DOI:10.1007/bf00953090
日期:1983.3
Langler Richard Francis, Steeves Jennifer Lea, Austral. J. Chem., 47 (1994) N 8, S 1641-1646